SCPHARMACEUTICALS INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
SCPHARMACEUTICALS INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$18.02 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2025-08-07
- SCPHARMACEUTICALS INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was -$18.02M.
- SCPHARMACEUTICALS INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was -$19.74M.
- SCPHARMACEUTICALS INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-12-31 was -$18.84M.
- SCPHARMACEUTICALS INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was -$35.10M.
- SCPHARMACEUTICALS INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$85.15M.
- SCPHARMACEUTICALS INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$54.81M.
- SCPHARMACEUTICALS INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$36.84M.
- SCPHARMACEUTICALS INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$28.03M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$18.02M 10-Q · filed 2025-08-07 | -$37.77M 10-Q · filed 2025-08-07 | -$56.61M derived: sum of 3 quarters · filed 2025-08-07 | -$91.72M derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | -$19.74M 10-Q · filed 2025-08-07 | -$38.59M derived: sum of 2 quarters · filed 2025-08-07 | -$73.69M derived: sum of 3 quarters · filed 2025-08-07 | -$90.78M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-12-31 | -$18.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$53.95M derived: sum of 2 quarters · filed 2025-03-19 | -$71.04M derived: sum of 3 quarters · filed 2025-08-07 | -$85.15M 10-K · filed 2025-03-19 |
| 2024-09-30 | -$35.10M 10-Q · filed 2024-11-13 | -$52.20M derived: sum of 2 quarters · filed 2025-08-07 | -$66.30M 10-Q · filed 2024-11-13 | -$80.11M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-06-30 | -$17.09M 10-Q · filed 2025-08-07 | -$31.20M 10-Q · filed 2025-08-07 | -$45.01M derived: sum of 3 quarters · filed 2025-08-07 | -$60.64M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$14.11M 10-Q · filed 2025-08-07 | -$27.92M derived: sum of 2 quarters · filed 2025-08-07 | -$43.55M derived: sum of 3 quarters · filed 2025-08-07 | -$57.71M derived: sum of 4 quarters · filed 2025-08-07 |
| 2023-12-31 | -$13.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | -$29.45M derived: sum of 2 quarters · filed 2025-03-19 | -$43.60M derived: sum of 3 quarters · filed 2025-03-19 | -$54.81M 10-K · filed 2025-03-19 |
| 2023-09-30 | -$15.63M 10-Q · filed 2024-11-13 | -$29.79M derived: sum of 2 quarters · filed 2024-11-13 | -$41.00M 10-Q · filed 2024-11-13 | -$50.25M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$14.15M 10-Q · filed 2024-11-13 | -$25.36M 10-Q · filed 2024-08-14 | -$34.61M derived: sum of 3 quarters · filed 2024-11-13 | -$44.77M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-03-31 | -$11.21M 10-Q · filed 2024-11-13 | -$20.46M derived: sum of 2 quarters · filed 2024-11-13 | -$30.62M derived: sum of 3 quarters · filed 2024-11-13 | -$40.32M derived: sum of 4 quarters · filed 2024-11-13 |
| 2022-12-31 | -$9.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$19.41M derived: sum of 2 quarters · filed 2024-03-13 | -$29.11M derived: sum of 3 quarters · filed 2024-03-13 | -$36.84M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$10.16M 10-Q · filed 2023-11-08 | -$19.86M derived: sum of 2 quarters · filed 2023-11-08 | -$27.59M 10-Q · filed 2023-11-08 | -$34.91M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$9.70M 10-Q · filed 2023-11-08 | -$17.43M 10-Q · filed 2023-08-10 | -$24.75M derived: sum of 3 quarters · filed 2023-11-08 | -$31.30M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-03-31 | -$7.73M 10-Q · filed 2023-11-08 | -$15.05M derived: sum of 2 quarters · filed 2023-11-08 | -$21.60M derived: sum of 3 quarters · filed 2023-11-08 | -$28.66M derived: sum of 4 quarters · filed 2023-11-08 |
| 2021-12-31 | -$7.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$13.87M derived: sum of 2 quarters · filed 2023-03-22 | -$20.93M derived: sum of 3 quarters · filed 2023-03-22 | -$28.03M 10-K · filed 2023-03-22 |
| 2021-09-30 | -$6.55M 10-Q · filed 2022-11-09 | -$13.61M derived: sum of 2 quarters · filed 2022-11-09 | -$20.72M 10-Q · filed 2022-11-09 | -$28.50M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$7.06M 10-Q · filed 2022-11-09 | -$14.16M 10-Q · filed 2022-08-09 | -$21.95M derived: sum of 3 quarters · filed 2022-11-09 | -$30.99M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-03-31 | -$7.10M 10-Q · filed 2022-11-09 | -$14.89M derived: sum of 2 quarters · filed 2022-11-09 | -$23.92M derived: sum of 3 quarters · filed 2022-11-09 | -$32.22M derived: sum of 4 quarters · filed 2022-11-09 |
| 2020-12-31 | -$7.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$16.82M derived: sum of 2 quarters · filed 2022-03-22 | -$25.12M derived: sum of 3 quarters · filed 2022-03-22 | -$32.21M 10-K · filed 2022-03-22 |
| 2020-09-30 | -$9.04M 10-Q · filed 2021-11-09 | -$17.33M derived: sum of 2 quarters · filed 2021-11-09 | -$24.43M 10-Q · filed 2021-11-09 | -$35.24M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$8.29M 10-Q · filed 2021-11-09 | -$15.39M 10-Q · filed 2021-08-11 | -$26.20M derived: sum of 3 quarters · filed 2021-11-09 | -$32.41M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-03-31 | -$7.09M 10-Q · filed 2021-11-09 | -$17.91M derived: sum of 2 quarters · filed 2021-11-09 | -$24.11M derived: sum of 3 quarters · filed 2021-11-09 | -$31.37M derived: sum of 4 quarters · filed 2021-11-09 |
| 2019-12-31 | -$10.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$17.02M derived: sum of 2 quarters · filed 2021-03-23 | -$24.28M derived: sum of 3 quarters · filed 2021-03-23 | -$33.00M 10-K · filed 2021-03-23 |
| 2019-09-30 | -$6.21M 10-Q · filed 2020-11-16 | -$13.46M derived: sum of 2 quarters · filed 2020-11-16 | -$22.18M 10-Q · filed 2020-11-16 | -$27.28M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$7.25M 10-Q · filed 2020-11-16 | -$15.97M 10-Q · filed 2020-08-13 | -$21.07M derived: sum of 3 quarters · filed 2020-11-16 | -$26.84M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-03-31 | -$8.72M 10-Q · filed 2020-11-16 | -$13.82M derived: sum of 2 quarters · filed 2020-11-16 | -$19.58M derived: sum of 3 quarters · filed 2020-11-16 | -$29.43M derived: sum of 4 quarters · filed 2020-11-16 |
| 2018-12-31 | -$5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | -$10.86M derived: sum of 2 quarters · filed 2020-03-24 | -$20.71M derived: sum of 3 quarters · filed 2020-03-24 | -$29.44M 10-K · filed 2020-03-24 |
| 2018-09-30 | -$5.76M 10-Q · filed 2019-11-12 | -$15.61M derived: sum of 2 quarters · filed 2019-11-12 | -$24.34M 10-Q · filed 2019-11-12 | -$31.22M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$9.85M 10-Q · filed 2019-11-12 | -$18.58M 10-Q · filed 2019-08-07 | -$25.46M derived: sum of 3 quarters · filed 2019-11-12 | -$30.95M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-03-31 | -$8.73M 10-Q · filed 2019-11-12 | -$15.61M derived: sum of 2 quarters · filed 2019-11-12 | -$21.10M derived: sum of 3 quarters · filed 2019-11-12 | |
| 2017-12-31 | -$6.88M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-21 | -$12.37M derived: sum of 2 quarters · filed 2019-03-21 | -$23.82M 10-K · filed 2019-03-21 | |
| 2017-09-30 | -$5.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$16.94M 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$11.45M 10-Q · filed 2018-08-14 | |||
| 2016-12-31 | -$24.38M 10-K · filed 2019-03-21 |